lobbying_activities: 3436312

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3436312	9282abcc-79cc-4a1f-a9db-c2f7c9b33559	Q3	ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)	400762305	AMERICAN PHARMACIES, INC.	2025	third_quarter	PHA	Issues related to independent pharmacy, including insurance coverage, network, and reimbursement; S. 526, Pharmacy Benefit Transparency Act; H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2025-10-16T11:40:16-04:00